Component | A | B | C | D |
---|
| Excellent | Good | Satisfactory | Poor |
Evidence base | | | | Q1 Q2 |
Consistency | | Q2a | Q1a | |
Clinical impact | | | Q2 | Q1 |
Generalisability | | | Q1 Q2 | |
Applicability | | | Q1 Q2 | |
- Q1 Question 1, Q2 Question 2
- aConsistency based on narrative synthesis rather than meta-analysis and I2
- The evidence base is assessed in terms of the quantity, level and quality (risk of bias) of the included studies
- Consistency assesses whether the findings are consistent across the included studies (including across a range of study populations and study designs)
- Clinical impact is a measure of the potential benefit from the application of the guideline to a population
- Generalisability assesses whether the subjects and settings of the included studies match the patient population being targeted and the clinical setting where the recommendation will be implemented
- Applicability addresses whether the evidence base is relevant to the Australian health care system generally